Rafaela Andrade Penalva Freitas, MD, PhD

Original Contribution

Ioxaglate Versus IoDixanol for the Prevention of Contrast-induced Nephropathy: The IDPC Trial

05/16/2023

Daniel Chamié , MD, PhD;

Aurea Chaves , MD, PhD;

Luiz Fernando Tanajura , MD, PhD;

Marinella Centemero , MD, PhD;

Rafaela Andrade Penalva Freitas , MD, PhD;

Davide Cao ;

Roxana Mehran , MD;

J. Ribamar Costa Jr., MD, PhD;

Amanda G.R.M. Sousa , MD, PhD;

Ricardo A. Costa , MD, PhD;

Fausto Feres , MD, PhD;

Sergio Navarro Braga , MD, PhD;

Despite the potential benefits of percutaneous procedures for the assessment and treatment of coronary artery disease, these interventions require the use of iodine contrast, which might lead to contrast-induced nephropathy (CIN) and...

Despite the potential benefits...

05/16/2023

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Rafaela Andrade Penalva Freitas, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products